These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 495293)

  • 21. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
    Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
    Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glibenclamide and glipizide in maturity onset diabetes. A double-blind cross-over study.
    Blohmé G; Waldenström J
    Acta Med Scand; 1979; 206(4):263-7. PubMed ID: 116480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
    Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
    Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
    [No Abstract]   [Full Text] [Related]  

  • 25. [A clinical study of a new sulfonylures hypoglycemic agent: glipizide (glibenese)(author's transl)].
    Cochet B; Balant L; Rilliet B; Zahnd G
    Schweiz Rundsch Med Prax; 1975 May; 64(18):562-8. PubMed ID: 1161734
    [No Abstract]   [Full Text] [Related]  

  • 26. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
    Lebovitz HE
    Pharmacotherapy; 1985; 5(2):63-77. PubMed ID: 3923454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus.
    Aman M; Jawad F; Sultana S; Waiz-ul-Haq ; Nanji R
    J Pak Med Assoc; 1977 Mar; 27(3):293-5. PubMed ID: 409862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics.
    Wåhlin-Boll E; Almér LO; Melander A
    Clin Pharmacokinet; 1982; 7(4):363-72. PubMed ID: 7116738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical trial with glipizide - a relative new sulphonylurea.
    Singarayar J; Sunderam S
    Med J Zambia; 1978; 12(4):97. PubMed ID: 398642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.
    Berchtold P; Björntorp P; Gustafson A; Jonsson A; Fagerberg SE
    Eur J Clin Pharmacol; 1971 Dec; 4(1):22-8. PubMed ID: 5151389
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.
    Greenfield MS; Doberne L; Rosenthal M; Vreman HJ; Reaven GM
    Arch Intern Med; 1982 Aug; 142(8):1498-1500. PubMed ID: 7103631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.
    De Leeuw I; De Baere H; Decraene P; Lemmens P; Verhaegen H
    Diabetologia; 1973 Sep; ():364-6. PubMed ID: 4204093
    [No Abstract]   [Full Text] [Related]  

  • 33. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired effect of sulfonylurea following increased dosage.
    Wåhlin-Boll E; Sartor G; Melander A; Scherstén B
    Eur J Clin Pharmacol; 1982; 22(1):21-5. PubMed ID: 7047168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glipizide--a new oral antidiabetic.
    El Saadani AM; Gaber A
    J Egypt Med Assoc; 1975; 58(11-12):649-53. PubMed ID: 1236493
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.
    Bitzén PO; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1988; 35(1):31-7. PubMed ID: 3065086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenesis of non-insulin-dependent diabetes: an update.
    DeFronzo RA; Ferrannini E
    Medicine (Baltimore); 1982 May; 61(3):125-40. PubMed ID: 7043155
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 39. Glipizide: an overview.
    Shuman CR
    Am J Med; 1983 Nov; 75(5B):55-9. PubMed ID: 6369968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diazoxide, glipizide, and hypoglycaemia.
    Greenwood RH; Mahler RF; Hales CN
    Lancet; 1977 Feb; 1(8006):307-8. PubMed ID: 64831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.